FDA grants NJ-based Merck approval for cervical cancer vaccine
(06/08/06) MORRISTOWN ? New Jersey-based Merck has been given approval by the Food and Drug Administration (FDA) to manufacture a vaccine designed to prevent cervical cancer in women. The ruling gives
